Cabaletta Bio Inc. (CABA)
NASDAQ: CABA
· Real-Time Price · USD
1.94
-0.05 (-2.51%)
At close: Jun 16, 2025, 3:59 PM
1.95
0.78%
Pre-market: Jun 17, 2025, 05:39 AM EDT
-2.51% (1D)
| Bid | 1.84 |
| Market Cap | 98.19M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -126.76M |
| EPS (ttm) | -2.54 |
| PE Ratio (ttm) | -0.76 |
| Forward PE | -0.88 |
| Analyst | Buy |
| Ask | 1.96 |
| Volume | 2,732,912 |
| Avg. Volume (20D) | 1,756,093 |
| Open | 2.01 |
| Previous Close | 1.99 |
| Day's Range | 1.77 - 2.00 |
| 52-Week Range | 0.99 - 10.54 |
| Beta | 2.79 |
About CABA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CABA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CABA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 days ago
-25.53%
Cabaletta Bio shares are trading lower after the c...
Unlock content with
Pro Subscription
1 month ago
+39.23%
Cabaletta Bio shares are trading higher after the company announced its eyeing a 2027 BLA submission for rese-cel in myositis after aliging with the FDA on registrations cohorts.
